Literature DB >> 9987821

Total synthesis and biological activity of lactacystin, omuralide and analogs.

E J Corey1, W D Li.   

Abstract

Lactacystin (1) and the related beta-lactone omuralide (2) are remarkably selective and potent irreversible inhibitors of the 20 S proteasome, a large polymolecular protein machine which is responsible for the degradation of ubiquitin-labeled proteins. Because of this fact 1 and 2 have emerged as important tools in biochemistry and cell biology. The challenge of synthesis has been accepted by several research groups with the result that 1 and 2 and their analogs can now be synthesized by a variety of synthetic approaches. This review summarizes the synthetic processes which have been developed to date for the production of such compounds. The study of biological activity of analogs of 1 and 2 has clearly defined the structural features which are responsible for the potency of 1 and 2, as described in the closing section of this account. It is concluded that 1 and 2 are nearly optimal for the irreversible inactivation of the 20 S proteasome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9987821     DOI: 10.1248/cpb.47.1

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  25 in total

Review 1.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

Review 2.  Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.

Authors:  Tobias A M Gulder; Bradley S Moore
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-03       Impact factor: 15.336

Review 3.  Highlights of marine invertebrate-derived biosynthetic products: their biomedical potential and possible production by microbial associants.

Authors:  Ocky K Radjasa; Yvette M Vaske; Gabriel Navarro; Hélène C Vervoort; Karen Tenney; Roger G Linington; Phillip Crews
Journal:  Bioorg Med Chem       Date:  2011-07-26       Impact factor: 3.641

Review 4.  Neurotrophic natural products: chemistry and biology.

Authors:  Jing Xu; Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  Angew Chem Int Ed Engl       Date:  2013-12-18       Impact factor: 15.336

5.  Engineered biosynthesis of antiprotealide and other unnatural salinosporamide proteasome inhibitors.

Authors:  Ryan P McGlinchey; Markus Nett; Alessandra S Eustáquio; Ratnakar N Asolkar; William Fenical; Bradley S Moore
Journal:  J Am Chem Soc       Date:  2008-05-31       Impact factor: 15.419

Review 6.  The 26 S proteasome: from basic mechanisms to drug targeting.

Authors:  Ami Navon; Aaron Ciechanover
Journal:  J Biol Chem       Date:  2009-10-07       Impact factor: 5.157

7.  Histone deacetylase inhibitors induce proteolysis of activated CDC42-associated kinase-1 in leukemic cells.

Authors:  Nisintha Mahendrarajah; Ramin Paulus; Oliver H Krämer
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-30       Impact factor: 4.553

8.  Concise total synthesis of (+/-)-salinosporamide A, (+/-)-cinnabaramide A, and derivatives via a bis-cyclization process: implications for a biosynthetic pathway?

Authors:  Gil Ma; Henry Nguyen; Daniel Romo
Journal:  Org Lett       Date:  2007-05-04       Impact factor: 6.005

9.  Discovery of novel proteasome inhibitors using a high-content cell-based screening system.

Authors:  Irena Lavelin; Avital Beer; Zvi Kam; Varda Rotter; Moshe Oren; Ami Navon; Benjamin Geiger
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

Review 10.  Generating a generation of proteasome inhibitors: from microbial fermentation to total synthesis of salinosporamide a (marizomib) and other salinosporamides.

Authors:  Barbara C Potts; Kin S Lam
Journal:  Mar Drugs       Date:  2010-03-25       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.